Baolingbao Biology Co.,Ltd. (SHE:002286)
China flag China · Delayed Price · Currency is CNY
8.96
+0.52 (6.16%)
Nov 5, 2026, 3:04 PM CST

Baolingbao Biology Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,8812,7512,4022,5242,7132,765
Revenue Growth
6.91%14.54%-4.84%-6.96%-1.89%34.58%
Gross Profit
397.45361.32278.47197.52308.4368.24
Operating Income
172.36172.45143.759.78156.58213.03
Net Income
130.64150.63111.1653.97133.17201.58
Earnings Per Share
0.360.410.300.150.360.54
EPS Growth
-8.12%36.67%100.00%-58.33%-33.33%285.71%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
China
2,0321,7901,7841,8621,843
Foreign
719.52611.53739.45851.14922.46
Total
2,7512,4022,5242,7132,765

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
294.65276.78254.95242.74375.95692.11
Total Debt
142.06126.54282.81304.13516.6411.88
Net Cash (Debt)
152.59150.24-27.86-61.39-140.65280.23
Net Cash Growth
125.79%----17.19%
Net Cash Per Share
0.420.41-0.08-0.17-0.380.75

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
316.93259.36248.72282.2830.82206.27
Capital Expenditures
-249.6-189.3-189.93-152.23-254.55-92.85
Free Cash Flow
67.3370.0758.79130.05-223.72113.42
Free Cash Flow Growth
-34.23%19.18%-54.79%---57.45%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
13.80%13.13%11.59%7.83%11.37%13.32%
Operating Margin
5.98%6.27%5.98%2.37%5.77%7.70%
Pretax Margin
5.44%6.46%5.46%2.58%5.78%8.56%
Profit Margin
4.54%5.47%4.63%2.14%4.91%7.29%
FCF Margin
2.34%2.55%2.45%5.15%-8.25%4.10%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1200.1200.0950.0800.0800.060
Dividend Per Share Growth
0%26.32%18.75%0%33.33%0%
Dividend Yield
1.34%1.34%1.29%0.98%0.88%0.44%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
24.9722.5924.5555.7925.3824.94
Forward PE
16.9116.7110.6910.6910.6922.67
P/FCF Ratio
50.5748.5646.4223.15-44.33
PS Ratio
1.181.241.141.191.251.82